Multiple sclerosis patients had fewer relapses with immediate treatment of clinically isolated disease but no improvement in disability outcomes, data from a randomized trial showed.
Patients who received immediate treatment with interferon had a 36% lower 10-year odds for progression to clinically definite MS and lower relapse rates at five and 10 years.
However, disability scores, MRI-visible lesions, and the rate of progressive disease at 10 years all did not differ between patients randomized to immediate or delayed treatment.
The findings are consistent with the previously reported five-year results of the trial, investigators reported online in Archives of Neurology.... Read More -
http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1765
Login
Register
FAQ
Search
